Zobrazeno 1 - 10
of 21
pro vyhledávání: '"A Aguirrezabal Arredondo"'
Autor:
T. Puig, L. Leache, N. M. González-Senac, E. Carreras, M. Gutiérrez-Valencia, L. Losa, J. L. Revuelta-Herrero, P. Marrero-Álvarez, M. de Miguel, A. Aguirrezabal Arredondo, A. Aranguren, A. Vilariño, V. E. Ruiz, I. Fernández, J. Bilbao, C. González-Guerrero, B. del Pino, N. Garin, on behalf of the MAPAC-MPC Network
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Purpose In recent years, the need for a more appropriate prescription of medications in the older population has emerged as a significant public health concern. In this study, we aimed to evaluate the prevalence of potentially inappropriate
Externí odkaz:
https://doaj.org/article/d6872b3f10f54b53bdc1bf4c6ec79f32
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Vila Gallego, MM Alvarez Lavin, MM Alonso Diez, M Vara Urruchua, A Revuelta Amallo, M Inclan Conde, NM Pardo Santos, AV Aguirrezabal Arredondo, J Muñoz Sanchez
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7f43d13b1b38b80f0a4b13fc5ac98be
https://doi.org/10.1136/ejhpharm-2022-eahp.409
https://doi.org/10.1136/ejhpharm-2022-eahp.409
Autor:
A Revuelta Amallo, C Vila Gallego, M Vara Urruchua, M Inclan Conde, B Belio Aguera, M Alvarez Lavin, M Alonso Diez, A Aguirrezabal Arredondo
Publikováno v:
Section 7: Post Congress additions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee813851416e5108e0714dae92aa4718
https://doi.org/10.1136/ejhpharm-2022-eahp.386
https://doi.org/10.1136/ejhpharm-2022-eahp.386
Autor:
U Idiazabal, A Ruiz Rodriguez, I Pereiro Lili, I Diez Gonzalez, A Atucha Salazar, E Amuriza De Luis, I Gorostiza Hormaetxe, J J Pascual Serrano, A Aguirrezabal Arredondo, J M Ormaetxe Merodio
Publikováno v:
European Heart Journal. 42
Patients who have undergone percutaneous coronary intervention (PCI) must be treated with dual antiplatelet therapy (DAPT) (aspirin and an adenosine diphosphate receptor antagonist (P2Y12)) to prevent thrombotic complications. However, this cornersto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41102a4bffa71393901bb6369c6408d9
https://doi.org/10.1093/eurheartj/ehab724.3001
https://doi.org/10.1093/eurheartj/ehab724.3001
Autor:
E Oñate Muzas, A Revuelta Amallo, E Tamayo Orbegozo, C Vila Gallego, U Blazquez Urtizberea, A Aguirrezabal Arredondo, S Vallinas Hidalgo, JA Dominguez Menendez, M Vara Urruchua
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The role of the pharmacist in the validation and dispensing of medications is already known. But the increasingly frequent use of high cost drugs makes that role essential for the sustainability of health systems. Aim and ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2338b55a903767109deee77a1e5279
https://doi.org/10.1136/ejhpharm-2021-eahpconf.144
https://doi.org/10.1136/ejhpharm-2021-eahpconf.144
Autor:
A Revuelta Amallo, E. Ruiz de Velasco Artaza, A Aguirrezabal Arredondo, M. Álvarez Lavín, J. Fernández Uria, M Alonso Diez
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance According to the 2017 updated guidelines from the European Society of Cardiology on dual antiplatelet therapy (DAPT), the optimal duration of DAPT remains a controversial topic. The decision must be dynamic and re-evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92650ae4c817938e4bda0a4e5f07de89
https://doi.org/10.1136/ejhpharm-2020-eahpconf.110
https://doi.org/10.1136/ejhpharm-2020-eahpconf.110
Autor:
JA Dominguez Menendez, A Aguirrezabal Arredondo, U Blazquez Urtizberea, I Martinez Aguirre, E. Fernández Díaz, M Alonso Diez, A Revuelta Amallo
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background and importance It has been proven that an updated pharmacotherapeutic report means improvements in patient safety and system efficiency. Aim and objectives To describe and analyse medicine reconciliation errors (MRE) and to determine aware
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13787c0033d4ba775feac58a71927428
https://doi.org/10.1136/ejhpharm-2020-eahpconf.305
https://doi.org/10.1136/ejhpharm-2020-eahpconf.305
Autor:
A Aguirrezabal Arredondo, A Llona Armada, JA Dominguez Menendez, I Martinez Aguirre, M Alonso Diez, M. Álvarez Lavín, U Blazquez Urtizberea
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background The neuropathic pain management which is refractory to opioids treatments demands the development of new analgesics or new ways of using our classic medicines. Ketamine is scarcely used as an anaesthetic, but with an increase in indication
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e76950af036886ec4f949ff40fe4f2af
https://doi.org/10.1136/ejhpharm-2019-eahpconf.313
https://doi.org/10.1136/ejhpharm-2019-eahpconf.313
Autor:
M Gutiérrez Toribio, JA Dominguez Menendez, MP Martínez del Prado, E Fernández Díez, MJ Yurrebaso Ibarreche, A Aguirrezabal Arredondo
Publikováno v:
European Journal of Hospital Pharmacy. 21:A1.3-A2
Background The new guidelines from the American Society of Clinical Oncology (ASCO) recommend full weight-based cytotoxic chemotherapy doses to treat obese patients with cancer, particularly when the goal is cure. Carboplatin is one exception and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d40c7bd81b1742b113fc1df7c9b0c4f
https://doi.org/10.1136/ejhpharm-2013-000436.3
https://doi.org/10.1136/ejhpharm-2013-000436.3